Overview
Uterovaginal malformation (Orphanet code 180062) is a broad category of congenital anomalies affecting the development of the uterus and vagina, which arise from the Müllerian (paramesonephric) ducts during embryonic development. These malformations encompass a wide spectrum of structural abnormalities, including uterine agenesis, unicornuate uterus, bicornuate uterus, septate uterus, didelphys uterus, vaginal agenesis, vaginal septum, and various combinations thereof. The condition primarily affects the female reproductive system and may also be associated with anomalies of the urinary tract and skeletal system, as these organ systems develop in close embryological proximity. Clinical presentation varies widely depending on the specific type and severity of the malformation. Some patients may be asymptomatic and diagnosed incidentally, while others present at puberty with primary amenorrhea, cyclic pelvic pain, or difficulty using tampons. In adulthood, uterovaginal malformations may be identified during evaluation for infertility, recurrent pregnancy loss, or obstetric complications such as preterm delivery or malpresentation. Specific well-known syndromes within this group include Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, characterized by congenital absence of the uterus and upper vagina in individuals with a normal female karyotype (46,XX) and normal secondary sexual characteristics. Diagnosis typically involves imaging studies such as pelvic ultrasound, magnetic resonance imaging (MRI), and sometimes hysteroscopy or laparoscopy. Treatment depends on the specific malformation and the patient's symptoms and reproductive goals. Surgical interventions may include hysteroscopic septum resection, vaginal dilation therapy or vaginoplasty for vaginal agenesis, and reconstructive procedures for obstructive anomalies causing pain or hematocolpos. Assisted reproductive technologies may be considered for patients with fertility challenges. A multidisciplinary approach involving gynecologists, reproductive endocrinologists, urologists, and psychologists is often recommended for comprehensive care.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventChinese University of Hong Kong
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Uterovaginal malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Uterovaginal malformation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Uterovaginal malformation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Uterovaginal malformation.
Community
No community posts yet. Be the first to share your experience with Uterovaginal malformation.
Start the conversation →Latest news about Uterovaginal malformation
Disease timeline:
New recruiting trial: Retrospective Review on Uterovaginal Anomalies
A new clinical trial is recruiting patients for Uterovaginal malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Uterovaginal malformation
What is Uterovaginal malformation?
Uterovaginal malformation (Orphanet code 180062) is a broad category of congenital anomalies affecting the development of the uterus and vagina, which arise from the Müllerian (paramesonephric) ducts during embryonic development. These malformations encompass a wide spectrum of structural abnormalities, including uterine agenesis, unicornuate uterus, bicornuate uterus, septate uterus, didelphys uterus, vaginal agenesis, vaginal septum, and various combinations thereof. The condition primarily affects the female reproductive system and may also be associated with anomalies of the urinary tract